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ABSTRACT The gene encoding testis-specific phospho-
glycerate kinase 2 (PGK; ATP:3-phospho-D-glycerate 1-
phosphotransferase, EC 2.7.2.3) is expressed only in meiotic
and haploid male germ cells. Transgenic mice containing an
8-kilobase human genomic PGK2 gene express the human gene
in a tissue-specific and developmentally regulated manner. To
determine the nature and location of sequences controlling this
expression, transgenic mice with various lengths of the human
PGK2 5' region fused to the chloramphenicol acetyltransferase
(CAT) gene were analyzed for expression. A 323-base-pair
region 5' to the coding region was found to contain information
essential for both tissue-specific and developmentally regulated
expression of the CAT reporter gene. Transgenic mice con-
taining a PGK2/luciferase-coding construct were compared
with mice containing gn equivalent CAT construct. Luciferase
gene expression was also testis-specific and was more sensitive
than CAT gene expression, but otherwise regulation of the two
reporter genes was similar in the germ cells of transgenic mice.
Translation of both PGK2/CAT and PGK2/luciferase fusion
genes was seen concurrently with the first detectable tran-
scripts.
Spermatogenesis involves a complex developmental program
including the progression of cells through mitotic, meiotic,
and haploid stages (for reviews, see refs. 1 and 2). Mitotically
dividing spermatogonia enter meiosis as spermatocytes and
then go through two cell divisions to become round sperma-
tids. These haploid cells undergo elongation, nuclear con-
densation, and other morphological changes, resulting in
mature spermatozoa.
In the mouse, spermatogenesis is an ongoing process that
begins soon after birth. Initial appearance of spermatogenic
cell types occurs synchronously, and the sequence of events
can be followed as a function of increasing age in a variety of
strains of inbred mice (3); At day-9 or -10 post partum,
spermatogonia first enter meiosis, by day-14 or -15 the first
pachytene spermatocytes are seen, and by day-22, haploid
round spermatids appear (3). The precise regulation of germ-
cell differentiation requires a controlled program of stage-
specific gene expression. To examine this process at the
molecular level, the mechanisms involved in the transcrip-
tional control of germ-cell-specific genes must be under-
stood. A well-characterized gene product expressed during
spermatogenesis and, therefore, a good candidate for molec-
ular analysis is the testis-specific isozyme for the glycolytic
enzyme phosphoglycerate kinase (PGK) (ATP:3-phospho-
D-glycerate 1-phosphotransferase, EC 2.7.2.3) (4-8).
In mammals PGK is encoded by two genes, Pgk-J and
Pgk-2 (PGKJ and PGK2 in human). Pgk-J is X-chromosome-
linked and expressed in somatic cells (6, 9, 10), whereas the
autosomal Pgk-2 gene is expressed only in meiotic and
haploid male germ cells (11, 12). Pgk-2 transcription is first
seen in pachytene spermatocytes, with message levels in-
creasing during later stages of spermatogenesis (12-14).
PGK-2 protein is not detected until 7 days later in haploid
round spermatids (6-8) and is coincident with the appearance
of Pgk-2 message on polysomes (12), suggesting additional
regulation at the translational level. Accordingly, analysis of
cis-acting regulatory elements of Pgk-2 may provide a basis
for understanding the control of gene expression during
spermatogenesis.
Human (13, 15, 16) and mouse (17) Pgk-2 genomic se-
quences have been cloned, and both genes lack introns and
share extensive homology. The sequences 5' to the coding
region are 66% homologous (17), and both genes exhibit
similar promoter motifs, consisting of the consensus se-
quences for the SP1 transcription factor (GC box) and for
nuclear factor 1 (CAAT box) (18, 19) (Fig. 1), rather than the
TATA consensus sequence found adjacent to the start of the
coding region in many genes (21). Given the reasonable
extent of homology, the ability to compare mouse and human
sequences for potential control elements, and the ease of
detecting the human gene in a mouse background, we chose
to define the extent of sequences required for appropriate
expression of the human PGK2 gene. We used transgenic
mice to assay for cis-acting elements that control stage and
cell type-specific gene expression.
Here we show that a human PGK2 gene fragment is
appropriately expressed in the mouse-and that all or part of
a 323-base-pair (bp) region 5' to the coding region of the
human PGK2 gene is necessary to direct testis-specific
expression of reporter genes.
MATERIALS AND METHODS
Gene Constructs. An 8-kilobase (kb) human genomic PGK2
EcoRI fragment (Fig. 2A). that contains the PGK2 coding
sequence flanked by 2.5 kb 5' and 4.25 kb 3' to the gene was
isolated for microinjection from a genomic clone generated
by Szabo et al. (15). The PGK2 5' region was isolated by
subcloning a 2.2-kb Sst I fragment containing 1.4 kb of the 5'
region and the first 0.8 kb of the coding region into mpl8,
converting the sequences across the initiation codon into a
HindIII site by site-directed mutagenesis, and isolating the
resulting 1.4-kb HindIII fragment. The PGK2/chloramphen-
icol acetyltransferase (CAT) fusion gene was constructed by
inserting the 1.4-kb fragment into the unique HindIII site of
the plasmid pSVOCAT (22). This PGK2/CAT plasmid was
digested with either Xba I, Pst I, or Ava II at the 5' end and
BamHI at the 3' end, and the resulting 3.1-kb, 2.2-kb, and
1.9-kb PGK2/CAT fragments (Fig. 2B) were each isolated for
microinjection. The PGK2/luciferase fusion gene (Fig. 2C)
was constructed by inserting the 1.4-kb HindIII 5' region
Abbreviations: PGK-2, phosphoglycerate kinase 2; CAT, chloram-
phenicol acetyltransferase; lu, luminometer unit.
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-520 CTGCAGAGGT TTTTACATAT CAAAATGGTT AAGATTTGAC ATGAATGAGG
-470 TGTATGTAGG TTTGCGGGGG TGGGGGTGGA GTTCTTTTTG TTTTGTTTTT
-420 AATAATAAAA GCAACTGTTA ACCGAGCTGT GIGGGGG CAAAAAGAGC
-370 CAGAAGCGGC GCACACCTCA GGACTATTCT TGTTTTTTTA GAACCATTCT
-320 TATTCTGGGG TTTCTTCACC TACCCAAGTC TCGCCTGAAG CCAGGTACAG
-270 CTCTATTCCA CTACATGACC CTCTGCCCAG GAAGTTGGAA TCTTCACCTA
AvaIIV
-220 GCAACACAGT TCAGATCGAG ATTGACAGGA CCATGZ3ACAAAGC
-170 TAGATTTGCT TTCAGTCTAA CAGTGGCCGT TGTGCTGGAG ACAGTAGGAG
-120 AAGAA ~AdAGG GCAAAGGCGT TAGAAGTCAC CACCGACCCA
-70 GCCCCTCAAC AGCAAGTTGG TTCTTCAGCA TTAAGATCCA GGTGTCAGCC
+1
-20 TATGTCTTTA TATTGTCAAG ATG
FIG. 1. The nucleotide sequence of the 5' region ofhuman PGK2.
Nucleotides are numbered relative to the first nucleotide of the
translation start codon (+1) and extend from the Pst I site at -515
bp relative to the initiation codon. The CAAT consensus sequence
(position -184 bp) and the GC consensus sequence (position -114
bp) are boxed. Restriction sites used for transgenic constructs are
indicated. The sequence was taken from McCarrey (20).
fragment into the unique HindIII site of the plasmid pSVOAL
(23) and isolating the 3.5-kb Xba I-BamHI fragment for
microinjection.
Transgenic Mice. Each of the five constructs was micro-
injected into fertilized eggs from superovulated (C57BL6J/
DBA2J) F1 females mated to males of the same cross.
Surviving eggs were then reimplanted into pseudopregnant
(C57BL6J/DBA2J) F1 females. Microinjection was per-
formed essentially as described (24). Founder transgenic
mice were identified by Southern blot hybridization using a
500-bp human PGK2 32P-labeled probe that spans the initia-
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FIG. 2. Constructs injected into fertilized mouse embryos. (A)
Structure of the genomic human PGK2 gene EcoRI fragment. This
8-kb fragment contains 2.5 kb 5' to the ATG initiation codon, a coding
region of 1.25 kb contained within a single exon, and 4.25 kb 3' to the
gene. (B) PGK2/CAT fusion constructs. 1.4 kb of the human PGK2
upstream region was placed into the HindI11 site of the plasmid
pSVOCAT, which contains the gene for CAT and simian virus 40
(SV40) poly(A) addition sequences. Restriction enzymes used to
isolate each fragment are shown, as are positions of the CAAT
consensus sequence (caat) and the SP1 binding-site consensus se-
quence (GC). (C) Structure of the PGK2/luciferase gene. The 1.4-kb
promoter region was inserted into the HindI11 site of pSVOAL that
contains the luciferase-coding region and the simian virus 40 poly(A)
addition sequences. The number of lines expressing the transgene
versus the number of lines tested is shown at right. A, Ava II; B,
BamHI; H, Hindll; R, EcoRI; PI Pst I; X, Xba I.
tion codon. Subsequent generations were identified by either
dot-blot hybridization or amplification of a 780-bp PGK2/
CAT fragment from 0.5 pug of genomic DNA using the
polymerase chain reaction (25).
RNA Analysis. Total RNA was extracted by tissue homog-
enization with 6 M urea/3 M LiCl, as described (26). North-
ern (RNA) analysis was done as described (27). The human
message was analyzed by using the same probe as that used
for Southern analysis. The endogenous mouse message was
assayed using a 32P-labeled probe from the 3' untranslated
region of the mouse Pgk-2 gene.
CAT Enzyme Assays. CAT assays were performed as
described (28). Protein extracts were prepared from tissues of
hemizygous male mice, and 30 jig of total protein was
incubated for 15 min to quantitate activity. The limit of
detection of CAT activity was determined by assaying serial
dilutions ofcommercially obtained CAT enzyme (Boehringer
Mannheim) of known activity. Calculations of specific activ-
ity and conversion to molecules of enzyme were based on a
native Mr of 80,000 (29) and a specific activity of 100,000
units/mg (Boehringer Mannheim), such that 1 unit of activity
corresponded to 6.2 x 1010 molecules of active tetramer. One
unit was defined as the conversion of 1 nmol of ['4C]chlor-
amphenicol to the 3'-acetyl form in 1 min at 250C.
Luciferase Enzyme Assays. Tissues were homogenized in a
Dounce homogenizer in phosphate-buffered saline, pH 8.0,
cellular debris was pelleted for 5 min at 12,000 x g, and
supernatants were assayed immediately. Extracts (10 ug of
total protein) were assayed in 100 mM Tris HCl, pH 7.5/15
mM MgSO4, 5 mM ATP; 1 mM D-luciferin was injected
immediately before recording with a Monolight 2001 lumi-
nometer (Analytical Luminescence Laboratory, San Diego,
CA). Peak light emission was measured, as it is both sensitive
and linear over several orders of magnitude. Calculations of
enzyme activity and number of luciferase molecules were
determined by using an Mr of 60,000 (23). Specific activity
and limit of detection measurements were determined based
upon serial dilutions of a solution of crystallized firefly
luciferase (Boehringer Mannheim) into testis extracts of
C57BL6J/DBA2J nontransgenic mice. It was determined
that 109 luminometer units (lu) were equivalent to 1 mg of
active luciferase protein, and it was then calculated that one
lu corresponds to 5 x 105 luciferase molecules.
RESULTS
Expression of Endogenous and Human PGK2 in Transgenic
Mice. To determine the pattern of expression of the human
PGK2 gene in transgenic mice, an 8-kb EcoRI genomic
fragment was purified and injected into single-cell fertilized
mouse embryos. This genomic fragment includes the entire
PGK2 coding sequence flanked by 2.5 kb upstream and 4.25
kb 3' to the gene (Fig. 2A). Six founder mice were identified
by hybridization to a human PGK2 probe. Lines were estab-
lished from three of the six founder mice, and each was
subsequently analyzed.
Murine Pgk-2 expression has been shown to be testis-
specific (4, 6) and developmentally regulated (7, 11, 14). To
determine the tissue specificity of the human PGK2 trans-
gene, total RNA was prepared from various tissues of adult
males from each of the three transgenic lines (designated P4,
P14, and P38), and expression of the transgene was analyzed
using Northern (RNA) blots. Expression of the human PGK2
RNA was testis-specific in all three lines tested. Line P14 was
bred to obtain animals that were homozygous for human
PGK2, and expression of the transgene in this line was
followed (Fig. 3A). Testes from homozygous mice contained
approximately twice the amount of transgene RNA per ug of
total RNA as the hemizygous testis, consistent with regula-
tion at the transcriptional level. Among the three transgenic
I
I
Proc. Natl. Acad. Scl. USA 86 (1989)
Ij
Proc. Natl. Acad. Sci. USA 86 (1989) 8439
a)
{
cn
A Testis a
+/+ +/- (-) iE
9(. 3
B Age (days) 1 3
>1 CC
C1) a) I-
c CD C) cCB Q >
Y cl J I
C)
- +t21 -
15 17 19 21 23 25 60 60 60
CAge (days) 13 15 17 19
2+.+3 ( (6-
21 23 25 60 60 60
FIG. 3. Expression of PGK2 in transgenic mice. (A) Northern
analysis of various tissues from transgenic line P14. Total RNA (20
,ug) from each of the tissues indicated was loaded per lane and probed
with human PGK2 sequences that share 70% homology to the mouse
Pgk-2 message. The faint band in the nontransgenic (-) testis lane is
presumed to be crosshybridization to the endogenous mouse Pgk-2
message. (B) Developmental expression of human PGK2 in homozy-
gous transgenic line P14. Total RNA was prepared from testes of line
P14 mice sacrificed between day-11 and day-60 (date of birth =
day-0). Twenty micrograms of total RNA per lane from the days
indicated was loaded and hybridized to the same probe as in A. (C)
Developmental expression of mouse Pgk-2. The filter in B was
stripped and reprobed with mouse Pgk-2 3' untranslated sequences.
This probe is 50% homologous to the human PGK2 sequence.
lines tested, however, there was no observed correlation
between the number of integrated copies of the human gene
and the level of human PGK2 message (unpublished results,
M.O.R.).
To determine the time during onset of spermatogenesis
when the human PGK2 transcript first appeared, RNA was
prepared from testes of line P14 homozygous mice between
day-11 and day-60. Transgene RNA was first detected at
day-15 and increased to a high level by day-60 (Fig. 3B).
Day-15 typically correlates with the appearance ofpachytene
spermatocytes (3). The presence of cytologically recogniz-
able pachytene cells in this line at day-15 was confirmed by
direct microscopic examination of dissociated testis cells. To
determine whether the human transgene showed the same
pattern of developmental expression as the endogenous
mouse Pgk-2 gene, the Northern blot was hybridized to a
mouse 3' specific probe at high stringency such that no
crosshybridization to the human transgene was seen. The
pattern of expression of mouse Pgk-2 was similar to the
pattern seen with the human probe (Fig. 3C). Therefore, it
was concluded that expression ofthe human PGK2 transgene
is regulated in a manner similar to that of the endogenous
Pgk-2 gene.
Promoter Analysis of Human PGK2. Having established
that the transgene functions in a tissue-specific and devel-
opmentally regulated manner, various deletions of the 5'
noncoding region were tested to map the cis-acting elements
involved in the transcriptional regulation ofPGK2. A 1.4-kb
HindIII fragment containing the promoter region of PGK2
that extends to, but does not include, the translation initiation
codon, was inserted into a unique HindIII site in pSVOCAT
(22). The resulting PGK2/CAT fusion gene places the CAT
gene under the control of the sequences 5' to the human
PGK2 coding region and uses the 3' untranslated region ofthe
simian virus 40 large tumor antigen gene to provide poly(A)
addition sequences. This construct was then used to generate
three different injection fragments, each containing the CAT
gene with different lengths of the PGK2 5' region. Fragment
lengths of 1.4 kb, 515 bp, and 192 bp were generated by
digesting the 5' end of the fusion gene with Xba I, Pst I, or
Ava II, respectively (Fig. 2B). The 192-bp site was chosen
because it marked the 5' end of the CAAT consensus
sequence, which functions as a transcriptional activator in
many cell types (18) and was, therefore, considered to be the
boundary of the minimal promoter.
Expression of PGK2/CAT Transgenes. Thirty mice born
from the 1.4-kb PGK2/CAT injections were analyzed using
Southern blot; six founder mice were identified, and lines
were derived from four of the founders (designated B4, B17,
B22, and B29). Two lines of mice (PS13 and PS28) were
established from the 515-bp PGK2/CAT construct, and three
lines (AV25, AV36, and AV41) were made from the 192-bp
PGK2/CAT fusion gene. Tissues of adult males from each of
the nine lines were tested for CAT activity by thin-layer
chromatography, and activity was measured using a scintil-
lation counter (Table 1). Tissues assayed were brain, heart,
lung, liver, kidney, intestine, muscle, and testis. Testis-
specific expression of the transgene was seen in three lines of
the 1.4-kb fragment construct (B17, B22, and B29), whereas
line B4 did not express the transgene. Both transgenic lines
containing the 515-bp PGK2 fragment also had CAT activity
restricted to the testes. By contrast, none of the three lines
containing the 192-bp fragment constructs exhibited CAT
activity in any tissue assayed. These results show that,
although efficient tissue specific expression could be directed
with 515 bp of upstream PGK2 sequences, expression was
eliminated by removing 323 bp between position -515 rela-
tive to the initiation codon and the minimal promoter ele-
ments that begin at -192 bp.
Table 1. CAT activity in testes of transgenic PGK-2/CAT lines
515-bp
1.4-kb promoter promoter 192-bp promoter
B4 B17 B22 B29* PS13 PS28 AV25 AV36 AV41
CAT activityt <0.03 1.04 0.59 1.37 0.44 0.78 <0.03 <0.03 <0.03
Tissue expressing enzyme None T T T T T None None None
T, testes. B4-AV41 are transgenic lines.
*Line B29 expressed the following CAT activity, in milliunits (mU) per ,ug, in testis: day-11, <0.03 mU; day-13, 0.05 mU;
day-14, 0.08 mU; day-15, 0.15 mU; and day-16, 0.14 mU.
tExpressed as milliunits per ,ug.
Developmental Biology: Robinson et al.
8440 Developmental Biology: Robinson et al.
To assay for the presence of regulatory elements between
1.4 kb and 515 bp that might affect the level of expression,
CAT activity was quantitated for all lines of mice carrying
these fragments. Constructs containing the 1.4-kb fragment
had 2-fold greater mean activity than those with the 515-bp
fragment (Table 1), a difference in level of activity that has
been seen between lines of a single construct. Therefore, no
cis-acting elements appear to exert any additional effect in
the region between the 1.4-kb fragment and the 515-bp
fragment.
The developmental regulation of the PGK2/CAT fusion
genes was assayed by monitoring the appearance of CAT
enzyme activity in extracts prepared from hemizygous testes
of line B29 (1.4-kb fragment) at days 11, 13, 14, 15, and 16.
CAT activity was first detected at a low level in extracts from
day-13 testes (footnote to Table 1), indicating that PGK2/
CAT transcript is present at day-13 and is likely to coincide
with the first appearance of pachytene spermatocytes. Line
PS28 (515-bp fragment) was also analyzed with respect to
developmental appearance of CAT activity, and a similar
pattern of expression was seen (data not shown). Previous
experiments have shown that mouse PGK-2 protein first
appears in spermatids (7, 12). However, CAT protein is
present before the appearance of spermatids, and develop-
mental Northern blot analysis of line B29 first detects PGK2/
CAT message at day-15 (unpublished work, M.O.R.). This
result shows that the transgene is not only transcriptionally
active, but also competent for translation ofthe CAT reporter
gene.
Luciferase Expression in the Testis. To increase sensitivity
and to determine whether the promoter could function inde-
pendently of the reporter gene, a parallel study was con-
ducted with transgenic mice in which the 1.4-kb upstream
region ofPGK2 was fused to the firefly luciferase gene. The
1.4-kb PGK2 HindIII fragment was inserted into the unique
HindIlI site of pSVOAL (23), which contains the luciferase-
coding region and simian virus 40 poly(A) addition se-
quences, and the resultant fusion gene (Fig. 2C was isolated
and injected into mouse embryos. Three founder mice were
identified, and breeding lines (PL4, PL5, and PL12) were
established for each.
Expression of the PGK2/luciferase fusion gene was ex-
amined by making protein extracts from various tissues of
hemizygous adult males of each line and assaying each
sample (10 ,g of total protein) in a luminometer for luciferase
activity (Table 2). In the presence of the substrate D-luciferin
and ATP, luciferase emits a transient peak of yellow light
with a decaying bioluminescence lasting several minutes (30).
PGK2/luciferase expression, measured by luciferase-cata-
lyzed peak photon production, was found to be testis-
specific. Testis extracts prepared from lines PL4 and PL12
gave signals of 1400 and 1600 lu per ug, respectively, whereas
all other tissues assayed (brain, heart, lung, liver, kidney,
intestine, muscle, and ovary) gave background readings (<10
lu). Line PL5 did not express the transgene in any tissue
assayed. To standardize the luciferase activity assay, ali-
quots of commercially prepared pure firefly luciferase were
tested in the same luminometer. Peak light emissions in the
linear range were recorded from 500 pg-50 fg; 50 fg corre-
Table 2. Luciferase activity in transgenic PGK2/luciferase lines
Transgenic line PL4 PL5 PL12*
Luciferase activityt 1400 <10 1600
Tissue expressing enzyme T None T
T, testes.
*Line PL12 expressed the following luciferase activity, in lu per .g
a)
12 14676
U)
.~-- --CAT Limit of Detection
106
---Luciferese Limit of Detection
4I5I //II
12 14 16 60
Age (days)
FIG. 4. Comparison of CAT and luciferase protein levels during
development. Enzyme activities were converted to molecules of
protein per ,ug of total protein in the extract to allow for direct
comparison. Molecules of reporter protein are plotted as a function
of the age of the mouse from which the protein extract was prepared.
Limit of detection for each respective reporter protein is indicated by
a dotted line. Ea, CAT protein level from line B29; *, luciferase
protein level from line PL12. All points represent single determina-
tions.
sponded to 10 lu, the limit of reliable detection in the
luminometer. Adding testis extracts from wild-type mice to
pure luciferase did not affect the activity, suggesting that no
inhibitory effect is present in the testis extract.
Developmental appearance of luciferase protein was ex-
amined for transgenic line PL12. Analysis of extracts of
prepuberal testes from males of this line on days 9, 12, 13, and
15 revealed luciferase activity first appearing at day-13 (foot-
note to Table 2), consistent with the appearance of CAT
activity in lines B29 and PS28. Apparently PGK2/luciferase
message is also competent for translation in pachytene cells.
To directly compare the sensitivity and accumulation of
each reporter enzyme, CAT and luciferase activities were
converted to molecules of enzyme by using published and
determined specific activities. Serial dilutions of commer-
cially obtained CAT enzyme into nontransgenic testis ex-
tracts established the limit of detection at 0.03 milliunits, or
2 x 106 molecules of CAT tetramer. The limit of detection of
luciferase enzyme was determined to be 10 lu or 5 X 105
molecules of luciferase protein, a 4-fold increase in sensitivity
over CAT detection levels. Plotting the activities of reporter
molecules in the transgenic lines B29 (CAT) and PL12
(luciferase) as a function of development (Fig. 4) demon-
strates that the reporter genes function in a similar fashion
with respect to accumulation of protein. Therefore, based on
identical tissue specificity, developmental appearance, and
accumulation kinetics, the control elements present in these
constructs appear not to be affected by the sequences present
in the reporter genes used.
DISCUSSION
Deletion analysis of the human PGK2 gene in transgenic mice
serves to define the extent of the sequences that encode
transcriptional control elements. A 323-bp region between
the functional 515-bp upstream region and the nonfunctional
192-bp sequence contains information essential for directing
testis-specific and developmentally regulated expression.
The 192-bp fragment contains sequence elements that are
probably essential for promoter function-e.g., the CAAT
box and GC box sequences (Fig. 1); however, these elements
clearly require the upstream sequences to function. This fact
is based on the observation that although none of the three
transgenic lines containing the 192-bp PGK2 fragment
of protein, in testis: day-9, <10 lu; day-12, <10 lu; day-13, 49 lu; and
day-iS, 149 lu.
tExpressed as lu per Ag.
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showed any expression, 10 of 12 transgenic lines containing
larger upstream regions exhibited testis-specific expression
of the PGK2 transgenes. Possibly elements located upstream
of the 1.4-kb location normally exert effects on the levels of
transcription of human PGK2; however, we have shown here
that such elements are not essential for proper expression.
Another germ-cell-specific gene the control regions of
which have been mapped is the mouse protamine 1-encoding
gene (Prm-1) (31). Although Prm-1 transcription initiates in
round spermatids and not in pachytene cells, comparison of
the regulatory regions ofPgk-2 and Prm-J provides candidate
sequence elements that may be involved in the control of
tissue-specific expression. Both Prm-J and human PGK2 5'
regions contain two copies each of the sequence GGGTGG-
GG, present in one orientation in PGK2 and in the opposite
orientation in the Prm-J gene (20). It is also found in the
upstream region of the Prm-2 gene in the same orientation as
PGK2 (20). This sequence could have a role in tissue-specific
gene expression; however, it should be noted that this
sequence has not been identified in the available upstream
sequence in the mouse Pgk-2 gene.
A study of genes expressed at different times during
spermatogenesis has resulted in the identification and cloning
of several cDNAs corresponding to transcripts that display a
pattern of expression nearly identical to that of Pgk-2 (14). If
Pgk-2 is one of a number of coordinately expressed genes,
then cis-acting elements responsible for the regulation of
Pgk-2 expression may be reiterated in the control regions of
these other genes. Elucidation of common cis-acting regula-
tory elements would establish a mechanism for coordinate
gene regulation at this time during spermatogfnesis.
We have shown that the PGK2/CAT and the PGK2/
luciferase fusion genes are translated concurrently with the
first observable PGK2 and PGK2 fusion gene transcripts.
Previous reports, however, suggest that translation of the
endogenous message is delayed (7, 12). This difference can be
the result of a number of effects. Possibly the PGK2/CAT
fusion genes are missing regulatory elements required for
translational control ofthe message, either because of species
differences between human and mouse Pgk-2 or because the
fusion gene is lacking the coding region and the 3' untrans-
lated sequences of the PGK2 message. Alternatively, it is
possible that although PGK2 and PGK2 fusion gene messages
are translationally controlled, a low rate of translation exists
in pachytene cells that is only detectable by using CAT and
luciferase reporter genes. PGK-2 protein, however, would
not be observed until the increased translational efficiency in
later cell types permitted detection.
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